A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the ...

Caleigh has struggled most of her life with a difficult lung disease, but she never lets it get the best of her.

Vertex Pharmaceuticals (NASDAQ: VRTX) has proven itself to be an excellent long-term investment, advancing 91% over the past ...

A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the triple-drug therapy ...

Therapeutics Market Size accelerated to USD 10.60 billion in 2024, up from USD 9.22 billion in 2023, and is now projected to expand aggressively to USD 35.09 billion by 2033, recording a CAGR of 14.2% ...

Among adults and adolescents with cystic fibrosis starting triple therapy for the first time, inflammatory markers fell and ...

Pediatric patients with cystic fibrosis starting triple combination therapy had larger relative improvements in 129Xenon MRI vs. lung function measures, according to data published in Annals of the ...

Cystic fibrosis is a genetic disease that causes a buildup of mucus in organs throughout your body. Stool may indicate how your gastrointestinal tract is functioning and whether or not treatment is ...

Shares of Arcturus Therapeutics ARCT have plunged 59.4% in the past three months. The massive stock price drop was primarily ...

Cystic fibrosis is caused by genetic changes and is always present at birth. Although rare, cystic fibrosis isn’t diagnosed in some people who have mild symptoms until they’re adults. This is known as ...